Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : Tokyo Joe's Cafe / Societe Anonyme/No Pennies -- Ignore unavailable to you. Want to Upgrade?

To: BarbaraT who wrote (82505)	7/8/1999 10:45:00 AM
From: Hope	Respond to of 119973

BXH & ARTE (about to merge) are both moving up. Anyone hear anything?

To: BarbaraT who wrote (82505)	7/8/1999 10:46:00 AM
From: cgraham	Read Replies (1) \| Respond to of 119973

Yes, it does seem I am a bit late on SGNT, but I think it still has some profit left to go.(or at least I hope so!) Wasn't watching NETO or ONES, but have been watching MANU EGGS and GERN. Like GERN the best so far.

To: BarbaraT who wrote (82505)	7/8/1999 10:50:00 AM
From: changedmyname	Read Replies (1) \| Respond to of 119973

ESPS-----> OVERLOOKED! Coverage Starts this next MONDAY. ADBE owns 32% of this company... and it's profitable. Great underwriters: H&Q, BancBoston, and Scwab to name a few. ESPS is the little white pill for companies showing symptoms of time-consuming regulatory filings. ESPS's (Electronic Submission Publishing Systems) foundation software, CoreDossier, helps pharmaceutical, biotechnology, and other companies electronically generate the large documents (up to 500,000 pages) required by regulatory agencies. Users pull data from other databases and compile it into reports that can be edited, published, distributed, and archived. Glaxo Wellcome, Hoechst, and Rhone-Poulenc account for about half of ESPS's sales. ESPS offers related compliance services and continues to expand into utilities, chemicals, and other document-intensive markets. Software firm Adobe Systems owns 32% of ESPS.